These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 29214453)

  • 1. Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications.
    Marchegiani G; Andrianello S; Nessi C; Sandini M; Maggino L; Malleo G; Paiella S; Polati E; Bassi C; Salvia R
    Ann Surg Oncol; 2018 Mar; 25(3):626-637. PubMed ID: 29214453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of neoadjuvant therapy on post-operative pancreatic fistula: a systematic review and meta-analysis.
    Kamarajah SK; Bundred JR; Boyle C; Oo J; Pandanaboyana S; Loveday B
    ANZ J Surg; 2020 Nov; 90(11):2201-2210. PubMed ID: 32418344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP.
    Krell RW; McNeil LR; Yanala UR; Are C; Reames BN
    Ann Surg Oncol; 2021 Jul; 28(7):3810-3822. PubMed ID: 33386542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy.
    McMillan MT; Christein JD; Callery MP; Behrman SW; Drebin JA; Hollis RH; Kent TS; Miller BC; Sprys MH; Watkins AA; Strasberg SM; Vollmer CM
    Surgery; 2016 Apr; 159(4):1013-22. PubMed ID: 26670325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of chemoradiation therapy provides strongest protective effect for avoidance of postoperative pancreatic fistula following pancreaticoduodenectomy: A NSQIP analysis.
    Mangieri CW; Strode MA; Moaven O; Clark CJ; Shen P
    J Surg Oncol; 2020 Dec; 122(8):1604-1611. PubMed ID: 32935353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
    Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
    Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Pancreatic Fistula and Long-term Survival in the Era of Neoadjuvant Chemotherapy.
    Hank T; Sandini M; Ferrone CR; Rodrigues C; Weniger M; Qadan M; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    JAMA Surg; 2019 Oct; 154(10):943-951. PubMed ID: 31411659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neoadjuvant therapy on postoperative outcomes after pancreaticoduodenectomy.
    Cools KS; Sanoff HK; Kim HJ; Yeh JJ; Stitzenberg KB
    J Surg Oncol; 2018 Sep; 118(3):455-462. PubMed ID: 30114330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer.
    Donovan EC; Prakash LR; Chiang YJ; Bruno ML; Maxwell JE; Ikoma N; Tzeng CD; Katz MHG; Lee JE; Kim MP
    J Gastrointest Surg; 2023 Feb; 27(2):319-327. PubMed ID: 36443557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
    Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
    Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative pancreatic fistula: We need to redefine grades B and C.
    Hackert T; Hinz U; Pausch T; Fesenbeck I; Strobel O; Schneider L; Fritz S; Büchler MW
    Surgery; 2016 Mar; 159(3):872-7. PubMed ID: 26603847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma.
    Rykina-Tameeva N; Nahm CB; Mehta S; Gill AJ; Samra JS; Mittal A
    HPB (Oxford); 2020 Nov; 22(11):1631-1636. PubMed ID: 32247587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Dominguez OH; Grigorian A; Wolf RF; Imagawa DK; Nahmias JT; Jutric Z
    Updates Surg; 2023 Apr; 75(3):523-530. PubMed ID: 36309940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide trends and outcomes of neoadjuvant chemotherapy in pancreatic cancer - an analysis of the Swedish national pancreatic cancer registry.
    Sternby H; Andersson B
    Scand J Gastroenterol; 2022 Nov; 57(11):1361-1366. PubMed ID: 35635264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative pancreatic fistulas decrease the survival of pancreatic cancer patients treated with surgery after neoadjuvant chemoradiotherapy: A retrospective analysis.
    Uchida Y; Masui T; Nagai K; Anazawa T; Yoshimura M; Uza N; Takaori K; Mizowaki T; Uemoto S
    Surg Oncol; 2020 Dec; 35():527-532. PubMed ID: 33160278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.
    Mostafa A; Habeeb TA; Neri V; Elshahidy TM; A Fiad A
    Ann Ital Chir; 2023; 94():435-442. PubMed ID: 38051507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TachoSil® in distal pancreatectomy: a single center experience.
    Silvestri S; Franchello A; Gonella F; Deiro G; Campra D; Cassine D; Fiore A; Ostuni E; Garino M; Resegotti A; Farina EC; Fronda GR
    Minerva Chir; 2015 Jun; 70(3):175-80. PubMed ID: 25960031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy.
    Wijetunga AR; Chua TC; Nahm CB; Pavlakis N; Clarke S; Chan DL; Diakos C; Maloney S; Ashrafi-Zadeh A; Kneebone A; Hruby G; Jamieson NB; Gill A; Mittal A; Samra JS
    Eur J Surg Oncol; 2021 Oct; 47(10):2543-2550. PubMed ID: 33952409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Study Group of Pancreatic Surgery Definitions for Postpancreatectomy Complications: Applicability at a High-Volume Center.
    Dusch N; Lietzmann A; Barthels F; Niedergethmann M; Rückert F; Wilhelm TJ
    Scand J Surg; 2017 Sep; 106(3):216-223. PubMed ID: 28376656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.